Kits Eyecare Achieves Record Revenues for Q2 2025

Published on August 7, 2025
VANCOUVER, British Columbia—Kits Eyecare Ltd. (TSX: KITS) yesterday announced revenue for the second quarter ended June 30, 2025. The company reported revenues of CA$49.6 million, representing a 31 percent increase compared with CA$37.9 million for the same quarter in 2024.
Continue reading on website
Other news

Another drop in the presbyopia bucket: Dr Bloomenstein shares his excitement for the FDA approval of Vizz

August 6, 2025
With FDA approval of LENZ Therapeutics’ Vizz (LNZ100), optometrists now have a daily, non-invasive treatment option for presbyopia, giving patients more freedom and clinicians greater flexibility in care.

How can myopia be controlled when only a small percentage of doctors attempt to control it?

August 7, 2025
Specialty care is always needed in any field, and myopia control is no exception.